据悉，2026年，上海将强化科技创新主体地位，完善覆盖科技型中小企业、专精特新和单项冠军企业、 高成长企业、科技领军企业的创新型企业梯度培育体系；预计新增50家以上先进智能工厂，积极培育智 能原生新模式新业态。 （文章来源：新华网） 记者从3日开幕的上海市第十六届人民代表大会第四次会议上获悉，2025年上海大力推动科技创新，完 善科技领军企业、高成长企业支持政策，全市日均新增科技企业超过320家，创新密度不断提升。 记者从会上获悉，2025年，上海全社会研发经费支出相当于全市生产总值的比例达到4.5%左右；工业 战略性新兴产业总产值增长6.5%，集成电路、生物医药、人工智能三大先导产业规模突破2万亿元。新 质生产力加快发展，有效助力上海经济社会发展稳中有进、进中提质。 截至2025年底，上海创新型中小企业超2.3万家，专精特新中小企业超1.3万家，专精特新"小巨人"企业 突破1000家。同时，上海已启动18家高质量孵化器，覆盖光电量子、智能传感、合成生物、细胞与基因 治疗等新兴产业领域和前沿赛道。 ...

Core Viewpoint - Shenzhen's GDP is projected to reach 38,731.80 billion yuan in 2025, with a year-on-year growth of 5.5%. Meanwhile, Pingshan District is expected to achieve a GDP growth of 10.5% during the same period, aiming for a doubling of its GDP over the "14th Five-Year Plan" period with an average annual growth rate in double digits [1][3]. Economic Growth - Pingshan District's GDP is set to grow by 10.5%, with industrial added value increasing by 15.9% and retail sales of consumer goods rising by 10.2%. The total social R&D investment intensity is expected to reach 11.8%, with 98.39% of this investment coming from enterprises [3][5][8]. - The total foreign trade import and export volume is projected to grow by 13.7% [8]. Industrial Development - Strategic emerging industries account for nearly 90% of the total industrial output value, with industrial investment making up 54% of fixed asset investment. The district is focusing on building a modern industrial system characterized by "vehicle, medicine, chip, and intelligence" [5][9]. - Pingshan is home to over 1,300 biopharmaceutical companies, and a partnership worth 1.64 billion USD has been established in the CAR-T field, setting a record for external licensing transactions in China [5][9]. Innovation and R&D - The social R&D investment intensity is projected to reach 11.8%, with a high innovation index. The district is launching initiatives to enhance technological innovation and has established various platforms for industry-academia collaboration [9]. - Pingshan is developing the first public service platform for vehicle-grade chip standard verification and has built a comprehensive traffic testing base for intelligent connected vehicles [9]. Consumer Market - Retail sales of consumer goods are expected to grow by 10.2%, with overall commodity sales increasing by 28.5%. The district has implemented policies to stimulate consumption, including a "trade-in" subsidy program [11][12]. - The accommodation and catering sectors are also experiencing growth, with accommodation revenue increasing by 7.6% and catering revenue by 4.0% [14]. Service Industry Performance - The software and information technology service industry is showing strong growth, with revenues increasing by 39.4%. The cultural, sports, and entertainment sectors are also performing well, with a revenue increase of 19.0% [15].

Core Insights - The article highlights the determination and confidence of the Gui Cheng street in Foshan to enter a new development phase, having officially become the first "billion-yuan street" in Guangdong province, with a GDP of 1001.33 billion yuan projected for 2025, two years ahead of the target [2][4]. Economic Performance - Gui Cheng street has achieved a GDP of 1001.33 billion yuan, making it the seventh town in China to surpass the billion-yuan mark [4]. - The street's economy is supported by Foshan's overall economic strength, with a total economic output exceeding 1.3 trillion yuan and industrial output surpassing 3 trillion yuan [4]. - The tertiary sector contributes nearly 70% to the economic growth of Gui Cheng, indicating a strong service industry presence [4]. Development Strategy - Gui Cheng aims to establish itself as a modern vibrant city by focusing on five key areas: enterprise aggregation, financial activity, resident satisfaction, tourist influx, and information utilization [6]. - The street plans to enhance its industrial ecosystem through a "three-pronged" strategy, focusing on headquarters economy, innovation in strategic emerging industries, and the integration of modern finance with traditional manufacturing [7]. Talent Attraction - To attract and retain talent, Gui Cheng is developing projects aimed at creating a youthful urban environment, including international performance venues and recreational facilities [8]. - The street is also improving urban infrastructure, such as schools and hospitals, to enhance living conditions for residents [8]. Infrastructure Development - Gui Cheng will focus on constructing three key areas: the Qian Deng Lake cultural tourism area, the Ying Yue Lake integrated production and city area, and the Wen Han Lake innovation hub, to connect with resources from the Greater Bay Area [9]. - The development will emphasize the integration of culture, commerce, and tourism, as well as collaboration with neighboring regions [9]. Supportive Environment - The street plans to strengthen land, capital, and data support to facilitate development, including optimizing the business and legal environment to ensure efficient operations [10]. - Gui Cheng aims to create a transparent and fair business environment through legal reforms and improved governance [10].

Core Viewpoint - The company reported a revenue of 793 million yuan for the year 2025, representing a year-on-year growth of 15.49%, and a net profit attributable to the parent company of 144 million yuan, with a year-on-year increase of 31.49% [1] Group 1: Financial Performance - The company's revenue increased by 15.49% year-on-year, primarily due to the expansion of its overseas sales network covering North America, Europe, and the Asia-Pacific regions, leading to a growing customer base and enhanced brand recognition [1] - The net profit attributable to the parent company reached 144 million yuan, reflecting a significant year-on-year growth of 31.49% [1] Group 2: Strategic Focus - The company is focusing on two core strategies: internationalization and innovation, which include continuous efforts to expand overseas markets and maintain high levels of R&D investment [1] - The company is developing new platforms based on universal underlying technologies, such as a fully human antibody platform and a microbiome research platform, to accelerate the transformation of R&D results and provide new growth points for development [1] Group 3: Market Dynamics - The domestic market has benefited from an increase in industry prosperity and a resurgence in R&D investments from downstream industrial clients, leading to a notable recovery in demand from industrial customers [1] - The functional efficacy business of the company has shown rapid revenue growth due to the recovery in demand from industrial clients [1]

Group 1 - The core viewpoint of the articles highlights the increasing activity of insurance capital in equity markets, particularly in Hong Kong stocks, driven by a low interest rate environment and asset scarcity [1][4] - Insurance capital has participated in cornerstone investments for seven Hong Kong IPOs in 2026, with a total subscription amount nearing 1 billion yuan, covering sectors from technology to consumer goods [1][2] - The cornerstone investment mechanism in Hong Kong serves as a market value indicator, with insurance capital becoming a key player in this space, particularly in new consumption and hard technology sectors [2][3] Group 2 - Notable examples of cornerstone investments include the IPO of Hunan Mingming Henmang Commercial Chain Co., which raised 3.336 billion HKD, attracting major institutions like Tencent and Temasek [2][3] - Insurance companies like Taikang Life have led the charge in Hong Kong IPOs, participating in multiple cornerstone investments across various sectors, including AI and biomedicine [3][4] - The trend of insurance capital's involvement in Hong Kong IPOs has significantly increased since 2025, with a total of 20 IPOs and a subscription amount of 4.679 billion HKD, reflecting the value of quality assets in the Hong Kong market [4] Group 3 - In addition to Hong Kong, insurance capital is actively researching A-share companies, having surveyed 310 firms in early 2026, focusing on sectors like technology and consumer goods [5][6] - The insurance sector's investment strategy includes a notable stake in Shanghai Airport, marking the first major acquisition of 2026, indicating a proactive approach in the A-share market [6] - The pre-made food sector, particularly companies like Qianwei Yangchu, has attracted attention from insurance capital, with significant revenue growth reported [6][7] Group 4 - The insurance capital's strategy is influenced by the need for asset allocation optimization and value recovery, as the Hong Kong market is currently at a historical valuation low, providing a safety margin [3][4] - Analysts suggest that the low interest rate environment necessitates increased investment in equity assets, particularly high-dividend and stable cash flow companies, to enhance investment returns [7][8] - The ongoing trend of insurance capital entering equity markets is expected to continue, driven by improved global liquidity and policy guidance encouraging long-term investments [4][7]

东方财富证券指出，从业绩兑现度看，近一个月超预板块仍集中在【涨价+AI】这两条景气主线上，且 AI硬件（元件、通信网络设备等）及涨价链（工业金属、能源金属、农化品等）的25Q4单季净利润预 告算术平均同比增速较25Q3均有进一步提升。近期以来电子元器件、小金属等品类陆续涨价。相比高 波动、高估值的资产，近期结构配置可适当沿着景气逻辑良好而本轮春季行情以来涨幅并未极致演绎的 板块挖掘，如电子元器件、通信等。 科创200ETF国泰（589220）跟踪的是科创200指数（000699），单日涨跌幅限制达20%，该指数从科创 板中选取市值较大、流动性较好的200只证券作为指数样本，覆盖了新一代信息技术、生物医药、新材 料、新能源等多个高新技术产业和战略性新兴产业，以反映科创板中代表性上市公司证券的整体表现。 （文章来源：每日经济新闻） ...

要点速览 1.进一步扩大服务消费，丰富数字消费、悦已消费、邮轮消费供给 8.更大力度培育壮大长期资本、耐心资本 9.加快建设小洋山北作业区、东方枢纽上海东站、浦东国际机场四期等重大项目 10.围绕智算光网、类脑智能等领域，培育前沿技术和颠覆性技术 2.推动一批国有企业重组整合、协同发展 3.加大国有控股上市公司市值管理力度 4.加强科创板制度建设 5.加强算力设施、行业语料、垂类模型等布局建设，推动新一代智能终端、智能体等广泛运用 6.推动深远海风电等重大项目建设，新增新型储能应用规模50万千瓦 7.在集成电路、生物医药、人工智能等领域加快实施一批重大产业项目 二是着力加强核心功能建设，持续提升"五个中心"能级。其中，围绕深化国际金融中心建设，上海将配 合中央金融管理部门纵深推进金融体制改革，加强科创板制度建设，推动银行间和交易所债券市场互联 上海市第十六届人民代表大会第四次会议2月3日上午在上海世博中心开幕。上海市市长龚正作政府工作 报告。 根据政府工作报告，综合各方面因素，建议2026年上海市经济社会发展的主要预期目标是：全市生产总 值增长5%左右，地方一般公共预算收入增长2%，全社会研发经费支出相当于全 ...

2026.02. 03 本文字数：1990，阅读时长大约3分钟 作者 | 第一财经 金叶子 具体包括加快重大科技成果高效转化应用；推进产业智能化、绿色化、融合化发展；一体推进教育科技人才发展几个方面。 例如，深化科技成果全部赋权改革，支持概念验证平台、中试平台、高质量孵化器提升服务能级。深入实施"人工智能+"行动，加强算力设施、行业语 料、垂类模型等布局建设，推动新一代智能终端、智能体等广泛运用，加快重点产业智能化改造，新增50家以上先进智能工厂。 2025经济总量位居全球城市第五的上海，划定新一年的发展目标。 上海市第十六届人大四次会议2月3日上午开幕。上海市市长龚正作《政府工作报告》（下称"报告"）。 报告称，建议今年全市经济社会发展的主要预期目标，是全市生产总值增长5%左右，地方一般公共预算收入增长2%，全社会研发经费支出相当于全市 生产总值的比例达到4.6%左右，城镇调查失业率5%以内，居民人均可支配收入增长与经济增长保持基本同步。 关于今年科技和产业工作的重点，报告提出，在2026年主要任务"持续提升 '五个中心'能级"方面，深化国际经济中心建设。积极支持智能网联新能源汽 车、海洋经济、低空经济、航 ...

Market Overview - Global markets experienced significant fluctuations, with the Hang Seng Index closing at 26,776, down 2.23% for the day but up 4.47% year-to-date [1] - The US markets showed a contrasting trend, with the Dow Jones increasing by 1.05% and the S&P 500 by 0.54% [1] - Asian markets faced a sell-off in commodities, with gold prices dropping below $4,400 and silver falling over 15% [3] Industry Insights - The heavy truck industry in China saw a 39% year-on-year increase in sales in January, attributed to a low base from the previous year and manufacturers meeting sales targets ahead of schedule [4] - The outlook for heavy truck demand remains optimistic, with expectations of maintaining over 1.1 million units in 2026, driven by a replacement cycle and continued government subsidies [4] Company Analysis - Gako's (1167 HK) focus on KRAS-targeted therapies positions it as a leader in the field, with a robust product pipeline and a partnership with AstraZeneca to accelerate development [4][5] - Gako's core product, JAB-23E73, is expected to achieve peak sales of $1.9 billion, highlighting its significant market potential [7] - The company has developed innovative platforms for antibody-drug conjugates (ADCs), which are anticipated to enhance treatment efficacy and safety [6] Financial Projections - Gako's target price is set at HKD 10.34, based on a discounted cash flow model, reflecting its strong growth potential in the KRAS market [7] - Mindray (425 HK) is projected to see stable growth driven by its battery box and robotics businesses, with revenue forecasts for the second half of 2025 adjusted upward by 1% to HKD 137 billion [8] - The company is expected to maintain a gross margin of 29.1% despite rising raw material costs, indicating effective cost management strategies [8] Strategic Partnerships - Stone Pharmaceutical (1093 HK) has entered a significant partnership with AstraZeneca, valued at over $18.5 billion, to advance multiple projects in weight management and diabetes [9][10] - This collaboration not only enhances Stone's pipeline but also validates its AI-driven drug discovery capabilities [9]

Group 1 - The major indices collectively rose on February 3, with the National Bio-Medical Index (399441) increasing by 1.15%. Notable stocks included Zhaoyan New Drug and Aimeike, both rising over 4%, while Tigermed and Huaxi Biological increased by over 3%, and Kailaiying rose nearly 3% [1] - The Bio-Medical ETF (159859) had a trading volume exceeding 65 million yuan, ranking first among its peers. The net inflow for this ETF on the previous trading day (February 2) was 67.29 million yuan, and it has seen continuous net inflows over the past 10 days, accumulating over 440 million yuan [1] - The latest circulating share of the Bio-Medical ETF is 9.569 billion shares, with a total market size of 3.674 billion yuan, making it the largest in its category [1] Group 2 - The Shanghai Municipal Government's work report emphasized the need to deepen the construction of an international economic center, focusing on modern industrial systems and supporting sectors such as bio-medicine, integrated circuits, and artificial intelligence [2] - According to Zhongtai Securities, the pharmaceutical market opportunities are expected to revolve around thematic opportunities, with potential performances in brain-computer interfaces, AI healthcare, and small nucleic acids. There is also a strategic emphasis on the raw material drug sector, which is at a bottom range and may see a mid-term positive cycle due to rising chemical prices and new business additions [2]